Dr. Daniel A. Husser
Dr. Daniel A. Husser is Dean Emeritus and Remington Professor Emeritus of the Philadelphia College of Pharmacy.
Part 1 (today's pharmacyMarch 2023) reviewed four new drugs in this series of new FDA-approved treatments coming to market in 2022: tirzepatide (Mounjaro-Lilly), dalidorexant hydrochloride (Quviviq-Idorsia), and tenapanol hydrochloride (Ibsrela). -Ardelyx), and with copackaged vonoprazan fumarate amoxicillin, amoxicillin and clarithromycin (Voquezna-Phathom).
CPE assessment
This assessment must be taken online. For more information, see “CPE Information” in the sidebar on the previous page. The online system presents these questions in a random order to enhance the learning opportunity. There is only one correct answer for each question.
CPE information
To earn 1 hour of CPE credit for this activity, complete the CPE exam and submit it online at www.pharmacist.com/education. A certificate of credit will be awarded for a passing score of 70% or above. There are two opportunities to complete the CPE exam. Pharmacists and technicians who successfully complete this activity by August 1, 2026 will receive credits. Upon successful completion of the CPE exam, your credentials will be immediately available online.
This policy is intended to maintain the integrity of CPE activity. Learners who successfully complete this activity by the expiration date will receive CPE credit. For credentials/transcripts, please visit CPE Monitor.
To claim a credit
1. Visit https://apha.us/CPE0823.
2. Log in to your APhA account or register as a new user.
3.[今すぐ登録]or[カートに追加]Choose ([カートを見る]and[チェックアウト]Click).
4. Complete the assessment and assessment.
5. Click Request Credit. To obtain and print your credentials, you must enter your NABP electronic profile ID number.
Get help at the APhA InfoCenter by calling 800-237-APhA (2742) or emailing infocenter@aphanet.org Monday through Friday from 8:30 a.m. to 5 p.m. Eastern Time. Available.
